Document Classification

Section Type: RESULTS

Text: Dual-hormone closed-loop delivery increased the percentage of time for which patients'plasma glucose levels were in the target range (median 70. 7 % [interquartile range (IQR) 46. 1 % -88. 4 %] for closed-loop delivery v. 57. 3 % [IQR 25. 2 % -71. 8 %] for control, p = 0. 003) and decreased the percentage of time for which plasma glucose levels were in the low range (bottom of target range [< 4. 0 mmol/L], 0. 0 % [IQR 0. 0 % -3. 0 %] for closed-loop delivery v. 10. 2 % [IQR 0. 0 % -13. 0 %] for control, p = 0. 01 ; hypoglycemia threshold [< 3. 3 mmol/L], 0. 0 % [IQR 0. 0 % -0. 0 %] for closed-loop delivery v. 2. 8 % [IQR 0. 0 % -5. 9 %] for control, p = 0. 006).